Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Dalhoff

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
The American Journal of Pathology|October 9, 2002
Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1Hanne Cathrine Bisgaard, Uffe Holmskov, Eric Santoni-Rugiu, et al.
BMJ Paediatrics Open|June 18, 2019
Interventional cohort study of prolonged use (>72 hours) of paracetamol in neonates: protocol of the PARASHUTE studySissel Sundell Haslund-Krog, Steen Hertel, Kim Dalhoff, et al.
Leukemia & Lymphoma|November 7, 2024
Drug exposure and measurable residual disease in chronic lymphocytic leukemia: a systematic reviewCathrine Korsholm, Cille Bülow, Mikkel Christensen, et al.
British Journal of Clinical Pharmacology|December 12, 2018
Obesity-induced CYP2E1 activity in childrenChristina Gade, Kim Dalhoff, Tonny Petersen, et al.
Frontiers in Toxicology|February 5, 2025
Editorial: Five grand challenges in toxicologyBengt Fadeel, Jan Alexander, Sara C Antunes, et al.
Clinical Pharmacokinetics|November 21, 2019
Midazolam Pharmacokinetics in Obese and Non-obese Children and AdolescentsChristina Gade, Eva Sverrisdóttir, Kim Dalhoff, et al.
Basic & Clinical Pharmacology & Toxicology|February 25, 2024
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classificationMorten Baltzer Houlind, Luise Hansen, Esben Iversen, et al.
British Journal of Clinical Pharmacology|June 23, 2023
Pharmacokinetics and safety of prolonged paracetamol treatment in neonates: An interventional cohort studySissel Haslund-Krog, Jessica M Barry, Angela K Birnbaum, et al.
Targeted Oncology|September 8, 2025
Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric PatientsTianwu Yang, Anna Sofie Buhl Rasmussen, Allan Weimann, et al.
British Journal of Clinical Pharmacology|May 28, 2026
Pharmacokinetic profiling of imatinib in relation to CYP3A4 activity in leukaemia patientsAnna Sofie Buhl Rasmussen, Mathilde Rønne Koch, Cecilie Utke Rank, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
The American Journal of Pathology|October 9, 2002
Heterogeneity of ductular reactions in adult rat and human liver revealed by novel expression of deleted in malignant brain tumor 1Hanne Cathrine Bisgaard, Uffe Holmskov, Eric Santoni-Rugiu, et al.
BMJ Paediatrics Open|June 18, 2019
Interventional cohort study of prolonged use (>72 hours) of paracetamol in neonates: protocol of the PARASHUTE studySissel Sundell Haslund-Krog, Steen Hertel, Kim Dalhoff, et al.
Leukemia & Lymphoma|November 7, 2024
Drug exposure and measurable residual disease in chronic lymphocytic leukemia: a systematic reviewCathrine Korsholm, Cille Bülow, Mikkel Christensen, et al.
British Journal of Clinical Pharmacology|December 12, 2018
Obesity-induced CYP2E1 activity in childrenChristina Gade, Kim Dalhoff, Tonny Petersen, et al.
Frontiers in Toxicology|February 5, 2025
Editorial: Five grand challenges in toxicologyBengt Fadeel, Jan Alexander, Sara C Antunes, et al.
Clinical Pharmacokinetics|November 21, 2019
Midazolam Pharmacokinetics in Obese and Non-obese Children and AdolescentsChristina Gade, Eva Sverrisdóttir, Kim Dalhoff, et al.
Basic & Clinical Pharmacology & Toxicology|February 25, 2024
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classificationMorten Baltzer Houlind, Luise Hansen, Esben Iversen, et al.
British Journal of Clinical Pharmacology|June 23, 2023
Pharmacokinetics and safety of prolonged paracetamol treatment in neonates: An interventional cohort studySissel Haslund-Krog, Jessica M Barry, Angela K Birnbaum, et al.
Targeted Oncology|September 8, 2025
Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric PatientsTianwu Yang, Anna Sofie Buhl Rasmussen, Allan Weimann, et al.
British Journal of Clinical Pharmacology|May 28, 2026
Pharmacokinetic profiling of imatinib in relation to CYP3A4 activity in leukaemia patientsAnna Sofie Buhl Rasmussen, Mathilde Rønne Koch, Cecilie Utke Rank, et al.
Pageof 10